Development and Evaluation of Modified Yoga in Systemic Lupus Erythematosus (SLE)
NCT01176643 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57
Last updated 2013-09-24
Summary
The purpose of this study is to test the effects of a modified yoga program in persons with SLE.
Conditions
Interventions
- OTHER
-
Standard care plus Yoga
Participants will be asked to complete two yoga classes weekly over a period of eight weeks.
Sponsors & Collaborators
-
McGill University Health Centre/Research Institute of the McGill University Health Centre
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-08-31
- Primary Completion
- 2012-05-31
- Completion
- 2013-08-31
Countries
- Canada
Study Locations
More Related Trials
-
Exercise and Systemic Lupus Erythematosus
NCT01515163 ·Status: UNKNOWN ·Phase: NA
-
Motivating Individuals With Lupus to Exercise
NCT05287581 ·Status: COMPLETED ·Phase: NA
-
Water-based Liuzijue Exercise on Childhood-onset Systemic Lupus Erythematosus
NCT07024082 ·Status: COMPLETED ·Phase: NA
-
Effect of Pioglitazone on Endothelial Function in Premenopausal Women With Uncomplicated Systemic Lupus Erythematosus
NCT01322308 ·Status: COMPLETED ·Phase: PHASE4
-
Mindfulness- Based Intervention for Systemic Lupus Erythematosus (SLE) Patients
NCT04305418 ·Status: COMPLETED ·Phase: NA
-
Comparison of Clinical and Serological Differences Among Juvenile, Adult, and Late-onset Systemic Lupus Erythematosus
NCT05724940 ·Status: UNKNOWN
-
Systemic Lupus Erythematosus
NCT05984316 ·Status: RECRUITING ·Phase: NA
-
The Incidence of Infection in Treatment of Low-dose IL-2 of SLE Patients
NCT04136106 ·Status: UNKNOWN
-
Serum IL 26 as a Marker of Disease Activity in SLE
NCT05161988 ·Status: UNKNOWN
-
Efficacy and Safety of Low-dose IL-2 in Patients With SLE: a Multicenter, Randomised, Placebo-controlled Trial
NCT04077684 ·Status: COMPLETED ·Phase: PHASE2
-
Low-dose IL-2( Interleukin-2) Treatment in SLE
NCT02084238 ·Status: COMPLETED ·Phase: NA
-
Effect of Insoles in Patients With Systemic Lupus Erythematosus
NCT04098055 ·Status: COMPLETED ·Phase: NA
-
Pilot Study to Investigate Contemplative Intervention in Lupus Patients
NCT03103243 ·Status: COMPLETED ·Phase: NA
-
Reducing Depressive Symptoms in Systemic Lupus Erythematosus
NCT01120652 ·Status: COMPLETED ·Phase: NA
-
Study of Individualized Instruction Versus Pamphlet in Systemic Lupus Erythematosus
NCT00004756 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Synbiotic Supplementation on IL-10, TGF-B and Disease Activity in Systemic Lupus Erythematosus Patients
NCT07048470 ·Status: COMPLETED ·Phase: NA
-
Sequential Belimumab and T-cell Based Therapy in SLE
NCT04447053 ·Status: UNKNOWN ·Phase: PHASE4
-
Telemedicine for Follow-up of Systemic Lupus Erythematosus
NCT04368299 ·Status: COMPLETED ·Phase: NA
-
Study of Endothelial Dysfunction in Systemic Lupus and Its Role in Heart Disease
NCT00188188 ·Status: UNKNOWN ·Phase: PHASE4
-
Feasibility and Safety of Acupuncture for Systemic Lupus
NCT00493753 ·Status: COMPLETED ·Phase: NA
-
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
NCT01405196 ·Status: COMPLETED ·Phase: PHASE2
-
Interleukin23 in Systemic Lupus
NCT06713187 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Immunological Evaluation of Belimumab Plus Low Dose IL-2 in the Treatment of Systemic Lupus Erythematosus
NCT05262686 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus
NCT02265744 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of High-intensity Interval Training in Patients With Systemic Lupus Erythematosus
NCT06166199 ·Status: RECRUITING ·Phase: NA